Health Care Reform: 2 Views

Health Care Reform: 2 Views STRIKING THE RIGHT BALANCE © Greg Betza We need to improve our healthcare system and allow the life science industries to flourish. By Sean Harper On healthcare reform it’s hard to find consensus. The one point everyone is in agreement on is that the current system is broken, and something must be done to fix it. The Obama administration and Congress are eager to enact

Written bySean Harper, Dennis J. Cotter, Mae Thamer, and Yi Zhang
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

We need to improve our healthcare system and allow the life science industries to flourish.

By Sean Harper

On healthcare reform it’s hard to find consensus. The one point everyone is in agreement on is that the current system is broken, and something must be done to fix it. The Obama administration and Congress are eager to enact broad reforms to improve care and access, and quickly. This is a commendable aim, one that Amgen fully supports. But in the rush to make change happen, it’s important to consider the long-term consequences of decisions made today.

Reforming the healthcare system can’t begin and end with cutting costs. Striking and maintaining the right balance between reform and preserving medical innovation and patient access will be challenging. Throughout the process, there are a few basic truths that should be kept in mind.

Bailed out by science

Manufacturing on a Grand Scale

The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies